PharmaEssentia (TPE:6446) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6446 PharmaEssentia Corp TPE:6446
80 GF Score
Price NT$1,180.00
GF Value NT$1,240.53
Valuation Fairly Valued
View Full Analysis

What is PharmaEssentia Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


PharmaEssentia  (TPE:6446) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


PharmaEssentia Cyclically Adjusted PB Ratio Related Terms


PharmaEssentia Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia Cyclically Adjusted PB Ratio Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.43 28.45 14.98 19.84 12.75

PharmaEssentia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.24 16.65 14.29 16.83 34.98

TPE:6446 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaEssentia Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PharmaEssentia's Cyclically Adjusted PB Ratio falls into.


TPE:6446
80GF Score
PharmaEssentia Corp TPE:6446
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

PharmaEssentia's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, PharmaEssentia's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=88.835/333.9520*333.9520
=88.835

Current CPI (Jun. 2026) = 333.9520.

PharmaEssentia Quarterly Data

Book Value per Share CPI Adj_Book
201609 16.201 241.428 22.410
201612 15.439 241.432 21.355
201703 14.803 243.801 20.277
201706 14.014 244.955 19.106
201709 13.337 246.819 18.045
201712 12.485 246.524 16.913
201803 11.731 249.554 15.698
201806 10.950 251.989 14.512
201809 10.164 252.439 13.446
201812 8.911 251.233 11.845
201903 8.041 254.202 10.564
201906 7.459 256.143 9.725
201909 6.591 256.759 8.573
201912 7.914 256.974 10.285
202003 6.979 258.115 9.030
202006 10.950 257.797 14.185
202009 15.234 260.280 19.546
202012 12.071 260.474 15.476
202103 9.742 264.877 12.283
202106 8.081 271.696 9.933
202109 5.957 274.310 7.252
202112 12.487 278.802 14.957
202203 11.658 287.504 13.541
202206 15.856 296.311 17.870
202209 15.463 296.808 17.398
202212 32.707 296.797 36.801
202303 32.443 301.836 35.895
202306 60.950 305.109 66.712
202309 58.560 307.789 63.538
202312 58.710 306.746 63.917
202403 59.752 312.332 63.888
202406 61.950 314.175 65.850
202409 63.768 315.301 67.540
202412 67.032 315.605 70.929
202503 71.036 319.799 74.180
202506 69.581 322.561 72.038
202509 80.469 324.800 82.736
202512 77.663 324.054 80.035
202603 83.515 330.213 84.461
202606 88.835 333.952 88.835

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is PharmaEssentia (TPE:6446) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be undervalued. The current stock price of NT$1,180.00 is trading 4.9% below its estimated GF Value™ of NT$1,240.53. GuruFocus considers PharmaEssentia to be Fairly Valued.

Key valuation signals for TPE:6446:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: NT$1,240.53 vs. price of NT$1,180.00 (4.9% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the TPE:6446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaEssentia Business Description

Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
80GF Score

Get the complete analysis for TPE:6446

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$1,180.00
Price
NT$1,240.53
GF Value